Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05513625 · ClinicalTrials.gov registry record · Phase 1
Potential Influence of Esomeprazole on the Pharmacokinetics of Pritelivir
A Phase 1 study, sponsored by AiCuris Anti-infective Cures.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT05513625: Completed Phase 1 study, sponsored by AiCuris Anti-infective Cures.
NCT05513625 is a Phase 1 study that has completed, run by AiCuris Anti-infective Cures. The registered enrollment target is 16 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05513625, a Phase 1 study, has completed, sponsored by AiCuris Anti-infective Cures.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
To investigate the effect of esomeprazole (ESO) on the pharmacokinetics of pritelivir (PTV), and to investigate the safety and tolerability of PTV.
Primary Outcome
Cmax - the maximum observed plasma concentration
Interventions
- DRUG Pritelivir
- DRUG ESO and pritelivir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2020-07-13 |
| Est. Completion | 2020-10-13 |
| Phase | Phase 1 |
What the finished NCT05513625 record still lists
NCT05513625 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 2 interventions - of which Pritelivir is the first listed.
NCT05513625 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05513625 about?
NCT05513625 is a clinical study titled "Potential Influence of Esomeprazole on the Pharmacokinetics of Pritelivir". To investigate the effect of esomeprazole (ESO) on the pharmacokinetics of pritelivir (PTV), and to investigate the safety and tolerability of PTV.
What is the current status of trial NCT05513625?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2020-07-13. Estimated completion is 2020-10-13.
What interventions are being tested in trial NCT05513625?
The interventions under investigation include: Pritelivir (DRUG), ESO and pritelivir (DRUG).
Who is sponsoring clinical trial NCT05513625?
This trial is sponsored by AiCuris Anti-infective Cures, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05513625's enrollment target sits among peer trials
16 1786th of 2000 higher than 203 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI